Core Viewpoint - Emergent BioSolutions Inc. will host a conference call on October 29, 2025, to discuss its financial results for the third quarter of 2025 [1]. Group 1: Conference Call Details - The conference call will take place at 5:00 pm eastern time [1]. - Participants can access the call via webcast or by visiting the Investors page of Emergent's website [2]. - Telephone participants must register in advance to receive a confirmation email with details on how to join the call, including a unique passcode and registrant ID [2]. Group 2: Company Overview - Emergent BioSolutions has been operational for over 25 years, focusing on public health protection [4]. - The company provides life-saving solutions for various health threats, including smallpox, mpox, botulism, Ebola, anthrax, and opioid overdose emergencies [4]. - Emergent aims to prepare communities for current health challenges and future threats [4].

Core Points - Emergent BioSolutions Inc. will be added to the Russell 3000 Index effective after the U.S. market closes on June 27, 2025, as part of the annual reconstitution of the Russell U.S. stock indexes [1][2] - The inclusion in the Russell 3000 Index is seen as a significant milestone in the company's transformation, indicating positive momentum and positioning for sustainable growth [2] - The Russell U.S. Indexes reconstitution captures the 4,000 largest U.S. stocks ranked by total market capitalization, with membership in the Russell 3000 Index providing automatic inclusion in either the large-cap Russell 1000 Index or small-cap Russell 2000 Index [2] Company Overview - Emergent BioSolutions has been focused on delivering protective and life-saving solutions for various health threats for over 25 years, including smallpox, mpox, botulism, Ebola, anthrax, and opioid overdose emergencies [5] - The company emphasizes its commitment to strong execution, financial stability, and long-term value creation for shareholders [2] Industry Context - Russell indexes are widely utilized by investment managers and institutional investors for index funds and as benchmarks for active investment strategies, with approximately $10.5 trillion in assets benchmarked against the Russell U.S. indexes as of December 2023 [3]

Core Insights - Emergent BioSolutions Inc. announced participation in several upcoming investor conferences, indicating active engagement with the investment community [1][3]. Company Overview - Emergent BioSolutions has a mission to protect and save lives, focusing on delivering solutions for health threats such as smallpox, mpox, botulism, Ebola, anthrax, and opioid overdose emergencies [2]. Upcoming Events - The company will participate in the RBC Global Healthcare Conference on May 20, 2025, with a fireside chat scheduled for 3:35 pm ET, available for virtual attendees via webcast [3]. - Emergent will also present at the Goldman Sachs Leveraged Finance Conference on May 29, 2025, in Dana Point, California [3]. - Additionally, the company is set to present at Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference on May 29, 2025 [3]. - The Jefferies Global Healthcare Conference presentation is scheduled for June 5, 2025, at 1:25 pm ET, also available for virtual participation [3].

GAITHERSBURG, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 7, 2025, at 5:00 pm eastern time to discuss the financial results for the first quarter of 2025. Participants can access the conference call live via webcast, and also by visiting the Investors page of Emergent's website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email ...